RAD Rite Aid Corporation

Rite Aid Supports National Influenza Vaccination Week with Discounted Flu Shots

From now through December 17, Rite Aid customers have the opportunity to save $5 on their flu shot in support of National Influenza Vaccination Week. The trivalent standard flu shot is available for $27.99, and the quadrivalent flu vaccine for $34.99.* Created by the Centers for Disease Control and Prevention (CDC) in 2005, National Influenza Vaccination Week (NIVW) is a national observance that was established to highlight the importance of continuing influenza vaccination, as well as fostering greater use of flu vaccine after the holiday season into January and beyond.

“National Influenza Week is the perfect time to remind people who haven’t received a flu shot yet that it is not too late to do so, as it is the best way to protect yourself and others from this potentially serious illness,” said Jocelyn Konrad, Rite Aid executive vice president of pharmacy. “Rite Aid pharmacists are committed to helping the communities we serve live and stay well, which is why we encourage customers to receive their flu shot annually.”

More than 11,000 Rite Aid certified immunizing pharmacists at Rite Aid pharmacies nationwide stand ready to vaccinate those who have not received their annual flu shot, subject to state regulations. Flu shots are covered by most insurance plans, including Medicare Part B and are available during pharmacy hours; no appointment is necessary. To locate the nearest Rite Aid pharmacy, visit www.riteaid.com or call 1-800-RITE-AID.

The CDC recommends a yearly flu vaccine for everyone 6 months of age and older as the first and most important step in protecting against this serious disease. Flu symptoms include cough, sore throat, fever, muscle aches, headaches, fatigue and running nose. Additional information about the upcoming flu season can be found at www.cdc.gov.

Receiving the annual flu shot also presents an opportunity to review other immunization needs. Rite Aid’s Vaccine Central, an assessment tool where visitors can complete a personal immunization evaluation, is an additional resource for people to further review immunization recommendations. To better understand personal immunization needs, customers can visit Rite Aid's Vaccine Central at www.riteaid.com/vaccinecentral, to complete an immunization evaluation, track their personal immunization history, and find other educational resources on immunizations.

Rite Aid Corporation (NYSE: RAD) is one of the nation's leading drugstore chains with nearly 4,600 stores in 31 states and the District of Columbia and fiscal 2016 annual revenues of $30.7 billion. Information about Rite Aid, including corporate background and press releases, is available through the company's website at www.riteaid.com.

*Vaccines available while supplies last. Age restrictions apply in some states. See pharmacist for details. Discount applies to cash price quadrivalent vaccine and standard trivalent flu shot only thru 12/17/16.

EN
05/12/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Rite Aid Corporation

Rite Aid Corporation: Rite Aid's bankruptcy accentuates drugstores' ne...

Drugstore retailers face many challenges including the need for scale to cover high fixed costs, high reimbursement risk, a growing number of online pharmacies and macroeconomic uncertainty.

Moody's downgrades Rite Aid's PDR to D-PD following Chapter 11 filing

Moody's Investors Service (Moody's) downgraded Rite Aid Corporation's ("Rite Aid") probability of default rating ("PDR") to D-PD from Caa3-PD. Moody's also downgraded the company's corporate family rating ("CFR") to Caa3 from Caa2, its senior secured ABL revolving credit facility rating to Caa1 from...

Rite Aid Corporation: Update following downgrade to Caa2 CFR and Caa3-...

Our credit view of Rite Aid reflects its weak interest coverage and 2025 debt maturities as well as its adequate liquidity and positive longer term trends of the prescription drug industry.

Moody's downgrades Rite Aid's CFR to Caa2; PDR to Caa3-PD

Moody's Investors Service ("Moody's") today downgraded Rite Aid Corporation's ("Rite Aid") corporate family rating ("CFR") to Caa2 from B3 and its probability of default rating ("PDR") to Caa3-PD from B3-PD. Moody's also downgraded the rating of Rite Aid's senior secured asset based revolving credit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch